✦ LIBER ✦

Antiphospholipid antibodies after renal transplantation and cardiovascular disease

✍ Scribed by Gema Fernández-Fresnedo; Marcos López-Hoyos; David San Segundo; Juan Crespo; Juan Carlos Ruiz; Angel Luis M De Francisco; Manuel Arias

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cardiovascular disease after pediatric r

✍ E. Kis; O. Cseprekal; A.A. Degi; A. Kerti; P. Sallay; A.J. Szabo; Gy Reusz 📂 Article 📅 2012 🏛 Atlantis Press 🌐 English ⚖ 38 KB

Antiphospholipid antibodies before and a

✍ David H Van Thiel; Magdalena George; John Brems; David Holt; Qianlong Zhu; Steve 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 59 KB

Cardiovascular risk factors and diseases

✍ S. Aker; K. Ivens; B. Grabensee; P. Heering 📂 Article 📅 1998 🏛 Springer Netherlands 🌐 English ⚖ 748 KB

Risk factors for cardiovascular disease

✍ J.M Díaz; Z Sainz; L.L Guirado; F Ortiz-Herbener; M Picazo; R Garcia-Camin; J Pa 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Cardiovascular complications after renal

✍ S Aker; K Ivens; Z Guo; B Grabensee; P Heering 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Use of Surrogate Outcomes for Cardiovasc

✍ Kevin C. Abbott 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 33 KB